Inventor · disambiguated record
Shengkan Jin
Also filed as: JIN SHENGKAN
5 granted patents·8 pending applications·5 citations·filing 2009–2025
68Inventor score
Top patents by PatentIndex Score
13 records- 0184US11479793B2Nuclease-independent targeted gene editing platform and uses thereofUNIV RUTGERS·Filed 2016·Granted Oct 25, 2022·4 cites·19 claims
- 0281US2025101464A1Nuclease-Independent Targeted Gene Editing Platform and Uses ThereofUNIV RUTGERS·Filed 2024·Application pending·0 cites
- 0374US10227315B2Mitochondrial uncouplers for treatment of metabolic diseases and cancerUNIV RUTGERS·Filed 2017·Granted Mar 12, 2019·1 cites·15 claims
- 0474US2024368628A1Targeted gene editing platform independent of dna double strand break and uses thereofUNIV RUTGERS·Filed 2024·Application pending·0 cites
- 0573US12188043B2Nuclease-independent targeted gene editing platform and uses thereofUNIV RUTGERS·Filed 2022·Granted Jan 7, 2025·0 cites·21 claims
- 0666US2025171808A1Nuclease-Independent Targeted Gene Editing Platform and Uses ThereofUNIV RUTGERS·Filed 2025·Application pending·0 cites
- 0760US2025163473A1Targeted gene editing platform independent of dna double strand break and uses thereofUNIV RUTGERS·Filed 2025·Application pending·0 cites
- 0858US12065666B2Targeted gene editing platform independent of DNA double strand break and uses thereofRUTGERS THE STATE UNIV·Filed 2018·Granted Aug 20, 2024·0 cites·20 claims
- 0957US2025109413A1Method for Producing Genetically Modified CellsUNIV RUTGERS·Filed 2022·Application pending·0 cites
- 1047US2022290134A1Highly Efficient DNA Base Editors Mediated By RNA-Aptamer Recruitment For Targeted Genome Modification And Uses ThereofUNIV RUTGERS·Filed 2020·Application pending·0 cites
- 1147US2011244059A1Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitorUNIV NEW JERSEY MED·Filed 2009·Application pending·0 cites
- 1238US10525021B2Mitochondrial uncouplers for treatment of metabolic diseases and cancerUNIV RUTGERS·Filed 2015·Granted Jan 7, 2020·0 cites·7 claims
- 1331US2013231312A1Treatment of type ii diabetes and diabetes-associated diseases with safe chemical mitochondrial uncouplersJIN SHENGKAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shengkan Jin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →